Ideal: A 28-week open-label extension of a 24-week double-blind study of the first transdermal patch in Alzheimer's disease

被引：0
|
作者：
Froelich, L. [1 ]
Barone, P. [2 ]
Foerstl, H. [3 ]
Onofrj, M. [4 ]
Nagel, J.
Ros, J. [5 ]
Tekin, S. [6 ]
Orgogozo, J. [7 ]
机构：
[1] Univ Heidelberg, Cent Inst Mental Hlth, D-6800 Mannheim, Germany
[2] Univ Naples Federico 2, Naples, Italy
[3] Tech Univ Munich, D-8000 Munich, Germany
[4] Gabriele DAnnunzio Univ Fdn, Chieti, Italy
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut Corp, E Hanover, NJ USA
[7] CHU Pellegrin, Bordeaux, France
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2007年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [41] Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension
    Jin, S. -M.
    Park, S. W.
    Yoon, K. -H.
    Min, K. W.
    Song, K. -H.
    Park, K. S.
    Park, J. -Y.
    Park, I. B.
    Chung, C. H.
    Baik, S. H.
    Choi, S. H.
    Lee, H. W.
    Lee, I. -K.
    Kim, D. -M.
    Lee, M. -K.
    DIABETES OBESITY & METABOLISM, 2015, 17 (05): : 511 - 515
  • [42] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, SA
    Williamson, D
    Case, M
    Lin, D
    Tohen, M
    BIPOLAR DISORDERS, 2005, 7 : 44 - 44
  • [43] Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study
    Nakamura, Yu
    Omori, Takumi
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 685 - 693
  • [44] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, S
    Williamson, D
    Case, M
    Lin, D
    Tohen, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S139 - S139
  • [45] Gabapentin as add-on therapy in children with refractory partial seizures: A 24-week, open-label extension study.
    Fichtner, K
    Appleton, R
    Murray, G
    Maton, S
    Alexander, J
    EPILEPSIA, 1999, 40 : 156 - 156
  • [46] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, SA
    Perlis, RH
    Keck, PE
    Lin, DY
    Case, MG
    Williamson, DJ
    Tohen, MF
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 798 - 806
  • [47] Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease
    Moebius, HJ
    Reisberg, B
    Schmitt, F
    Doody, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S388 - S389
  • [48] Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan
    Ueda, Kengo
    Katayama, Sadao
    Arai, Tetsuaki
    Furuta, Nobuo
    Ikebe, Shinichiro
    Ishida, Yoshinori
    Kanaya, Kiyoshi
    Ouma, Shinji
    Sakurai, Hirofumi
    Sugitani, Masato
    Takahashi, Makio
    Tanaka, Toshihisa
    Tsuno, Norifumi
    Wakutani, Yosuke
    Shekhawat, Ankita
    Das Gupta, Ayan
    Kiyose, Kazuki
    Toriyama, Kazuhiro
    Nakamura, Yu
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2019, 9 (02) : 302 - 318
  • [49] Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
    Ringman, John M.
    Frautschy, Sally A.
    Teng, Edmond
    Begum, Aynun N.
    Bardens, Jenny
    Beigi, Maryam
    Gylys, Karen H.
    Badmaev, Vladimir
    Heath, Dennis D.
    Apostolova, Liana G.
    Porter, Verna
    Vanek, Zeba
    Marshall, Gad A.
    Hellemann, Gerhard
    Sugar, Catherine
    Masterman, Donna L.
    Montine, Thomas J.
    Cummings, Jeffrey L.
    Cole, Greg M.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (05)
  • [50] Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
    Edwards, Keith
    Royall, Donald
    Hershey, Linda
    Lichter, David
    Hake, Ann
    Farlow, Martin
    Pasquier, Florence
    Johnson, Stewart
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (06) : 401 - 405
12345